XML 28 R13.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Current Accrued Liabilities | 12 Months Ended
--- | ---
Dec. 31, 2015
Disclosure Component Of Current Accrued Liabilities [Abstract] |
Current Accrued Liabilities |
6. | Current Accrued Liabilities
Current accrued liabilities consist of the following (in thousands):
| December 31, |
| 2015 |  |  | 2014 |
Payroll and related expenses | $ | 5,866 |  |  | $ | 4,613 |
Legal expenses |  | 202 |  |  |  | 224 |
Third party research expenses |  | 5,241 |  |  |  | 5,898 |
Third party development expenses |  | 2,072 |  |  |  | 1,000 |
Return of funding due to AstraZeneca AB (“AstraZeneca”) (Note 9) |  | 7,345 |  |  | - |
Other accrued liabilities |  | 1,972 |  |  |  | 1,520 |
Total | $ | 22,698 |  |  | $ | 13,255 |

X
- Definition Disclosure component of current accrued liabilities. + References No definition available. + Details
Name: | dvax_DisclosureComponentOfCurrentAccruedLiabilitiesAbstract
Namespace Prefix: | dvax_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References No definition available. + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration